Aging is associated with decline in muscle mass and muscle functions. Muscle strength declines disproportionate to the decline in muscle mass indicating that muscle quality or protein quality also declines with age. Human studies have shown a progressive decline in muscle protein synthesis including proteins in the contractile apparatus and mitochondria with age. However, the decline in muscle protein synthesis is disproportionate to the decline in muscle mass that occurs with age prompting to hypothesize that muscle protein degradation also declines with age. A decline in mitochondrial capacity to synthesize ATP is likely a limiting factor of both synthesis and degradation, which are ATP dependent processes. In support of the above hypothesis, several studies have shown a decline in whole body protein turnover (synthesis and degradation). The timely and efficient degradation of irreversibly damaged or modified proteins is critical to maintain the quality of protein. It is proposed that a failure to degrade the damaged proteins and replacing them with newly synthesized proteins contribute to age related decline in muscle mass and quality of muscle proteins. The underlying molecular mechanism of these age related changes in human muscle needs further investigation.
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Introduction
The world's elderly population is rapidly expanding, exerting huge socioeconomic ramifications due in part to the concomitant increase in age-related comorbidities and the onset of many diseases that manifest with aging in people who may have genetic predisposition. It is well recognized that aging is associated with the progressive decline in skeletal muscle mass, strength, and function, collectively known as sarcopenia (Roubenoff, 2000) . Sarcopenia is a major cause of frailty, physical disability, and loss of functional independence among the elderly (Morley et al., 2011) .
Nematodes (Herndon et al., 2002) , rodents (Altun et al., 2007) , nonhuman primates (Nemoz-Bertholet and Aujard, 2003), and humans (Short et al., 2005) all demonstrate progressive age-related declines in physical activity. This age-related decline in physical activity is likely due to the progressive loss of skeletal muscle mass, muscle strength, and endurance. These age-related decreases in physical activity further contribute to the manifestation of sarcopenia and its related disorders. Specifically, sarcopenia likely contributes to the development of insulin resistance, type 2 diabetes, and cardiovascular disease. There are emerging data in various species ranging from nematodes (Herndon et al., 2002) to humans (Talbot et al., 2007) indicating that declining activity levels lead to increased mortality. Therefore, there is a critical need to develop therapeutic strategies to prevent or delay the onset of sarcopenia.
The primary aim of this review is to examine the underlying mechanisms that contribute to the development of sarcopenia. We will also examine the therapeutic impact that endurance and resistance training have on aged skeletal muscle. Since proteins are the main functional molecules and constitute the predominant non-fluid lean mass, we hypothesize that the age-related loss of skeletal muscle mass, strength, and function are due to impairments in overall skeletal muscle protein homeostasis (the balance between protein synthesis and protein breakdown). The functions of proteins are determined not only by their concentrations but also by their quality. Removal of damaged proteins by degradation and their replacement by newly synthesized proteins are critical for maintaining the quality of the proteins. We posit that both declines in skeletal muscle protein synthesis and degradation play equally important roles in the development of sarcopenia and age-related skeletal muscle dysfunction. Here we discuss the regulation of protein synthesis and degradation and how alterations in these processes may cause sarcopenia.
